Brainsway Ltd. (BRIN) declined the most in four months as the developer of a device for neurological disorders said its chief executive officer will step down and a partnership with a U.S. distributor was terminated.
Brainsway fell 8.4 percent to 31.41 shekels ($8.02) at the close in Tel Aviv, the steepest decline since Aug. 20. Trading volume was six times higher than the three-month average. The shares are down 30 percent this year.
Help employers find you! Check out all the jobs and post your resume.
Brainsway fell 8.4 percent to 31.41 shekels ($8.02) at the close in Tel Aviv, the steepest decline since Aug. 20. Trading volume was six times higher than the three-month average. The shares are down 30 percent this year.
Help employers find you! Check out all the jobs and post your resume.
